Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 13.58%, near the low end of its 5-year range (0.00%–99.89%).
As of the fiscal period ended Tuesday, March 31, 2026. 100.00% below its 12-month average of 1.33%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2026 (2026-03-31): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
1.33%
DEBT TO ASSETS RATIO AVG 3Y
20.93%
DEBT TO ASSETS RATIO AVG 5Y
13.58%
DEBT TO ASSETS RATIO AVG 10Y
0.22%
DEBT TO ASSETS RATIO AVG 15Y
0.00%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
OKYO Pharma Limited
Market Cap
$56.02M
Debt to Assets Ratio
0.00%
TTM Avg
1.33%
3Y Avg
20.93%
5Y Avg
13.58%
Market Cap
$57.01M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$57.76M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$54.14M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.06M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.29M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.70M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OKYO Pharma Limited (OKYO) | $56.02M | 0.00% | 1.33% | 20.93% | 13.58% |
| Aldeyra The (ALDX)vs › | $55.25M | 0.00% | N/A | N/A | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | 0.01% | N/A | N/A | N/A |
| Talphera, Inc. (TLPH)vs › | $57.61M | 0.00% | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | 0.00% | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $54.14M | 0.06% | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | 0.01% | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | 0.00% | N/A | N/A | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | 0.04% | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | 0.09% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
2.43
Interest Coverage
-17.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-03-31 | 0.00% |
| 2025-09-30 | 4.00% |
| 2025-03-31 | 0.00% |
| 2024-09-30 | 0.06% |
| 2024-03-31 | 0.00% |
| 2023-09-30 | 99.89% |
| 2023-03-31 | 42.57% |
| 2022-10-01 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-09-30 | 1.45% |
| 2021-03-31 | 1.39% |
| 2020-09-30 | 0.38% |
| 2020-03-31 | 5.29% |
| 2019-09-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2017-09-30 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-03-31 | 0.00% |
